Brooklyn, NY, United States of America

Cheng Guo

USPTO Granted Patents = 6 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations in Nucleotide Sequencing by Cheng Guo

Introduction

Cheng Guo is a prominent inventor based in Brooklyn, NY, known for his significant contributions to the field of nucleotide sequencing. With a total of six patents to his name, Guo has made remarkable advancements that enhance the methods used in genetic research and biotechnology.

Latest Patents

Among his latest patents, Guo has developed innovative nucleotide derivatives and methods of use thereof. These patents disclose compounds, compositions, and methods that facilitate the sequencing of nucleic acids. Another notable patent focuses on the synthesis of novel disulfide linker-based nucleotides, which serve as reversible terminators for DNA sequencing by synthesis. These advancements are crucial for improving the efficiency and accuracy of genetic sequencing techniques.

Career Highlights

Cheng Guo is affiliated with Columbia University, where he conducts research and develops new technologies in the field of molecular biology. His work has garnered attention for its potential applications in various scientific and medical fields, particularly in genomics and personalized medicine.

Collaborations

Guo collaborates with esteemed colleagues, including Jingyue Ju and Xiaoxu Li, who contribute to his research endeavors. Their combined expertise fosters an environment of innovation and discovery, further enhancing the impact of their work in nucleotide sequencing.

Conclusion

Cheng Guo's contributions to nucleotide sequencing through his patents and research at Columbia University highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in genetic research and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…